Assignee
GLADIUS PHARMACEUTICALS CORP
CA·7 granted patents·36 citations·filing 2014–2018
Top patents by PatentIndex Score
7 records- 0193US10000509B2Broad spectrum beta-lactamase inhibitorsGLADIUS PHARMACEUTICALS CORP·Filed 2017·Granted Jun 19, 2018·6 cites·21 claims
- 0293US9453032B2Broad spectrum beta-lactamase inhibitorsGLADIUS PHARMACEUTICALS CORP·Filed 2014·Granted Sep 27, 2016·11 cites·25 claims
- 0392US9809605B1Broad spectrum beta-lactamase inhibitorsGLADIUS PHARMACEUTICALS CORP·Filed 2017·Granted Nov 7, 2017·6 cites·20 claims
- 0490US10239890B2Broad spectrum beta-lactamase inhibitorsGLADIUS PHARMACEUTICALS CORP·Filed 2018·Granted Mar 26, 2019·4 cites·20 claims
- 0588US9862729B2Broad spectrum beta-lactamase inhibitorsGLADIUS PHARMACEUTICALS CORP·Filed 2016·Granted Jan 9, 2018·6 cites·46 claims
- 0682US9975905B2Derivatized 3-styryl-cephalosporinsGLADIUS PHARMACEUTICALS CORP·Filed 2014·Granted May 22, 2018·3 cites·16 claims
- 0759US11028103B2Derivatized 3-styryl-cephalosporinsGLADIUS PHARMACEUTICALS CORP·Filed 2018·Granted Jun 8, 2021·0 cites·11 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →